Osteopontin (OPN) is an extracellular matrix protein that is also involved in the regulation of inflammatory response [68], fibrosis and vascular remodelling [69], and it may be a promising diagnostic and prognostic biomarker in CTD-PAH patients. The gene discussed is SPP1; the disease is pulmonary arterial hypertension.